COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,893 Articles (22,568 medRxiv, 8,325 bioRxiv)

Most recent first Previous |  Page 3047: Articles 30461-30470  | Next

Amplicon based MinION sequencing of SARS-CoV-2 and metagenomic characterisation of nasopharyngeal swabs from patients with COVID-19
Moore, S. C., Penrice-Randal, R., Alruwaili, M., Dong, X., Pullan, S. T., Carter, D., Bewley, K., Zhao, Q., Sun, Y., Hartley, C., Zhou, E.-m., Solomon, T., Beadsworth, M. B. J., Cruise, J., Bogaert, D., Crook, D. W. T., Matthews, D. A., Davidson, A. D., Mahmood, Z., Aljabr, W., Druce, J., Vipond, R. T., Ng, L., Renia, L., Openshaw, P., Baillie, J. K., Carroll, M. W., Semple, C., Turtle, L., Hiscox, J. A.
10.1101/2020.03.05.20032011 — Posted: 2020-03-08 Discussion: Offsite
CORONAVIRUS IN PREGNANCY AND DELIVERY: RAPID REVIEW AND EXPERT CONSENSUS
Mullins, E., Evans, D., Viner, R., O'Brien, P., Morris, E.
10.1101/2020.03.06.20032144 — Posted: 2020-03-08
Substrate specificity profiling of SARS-CoV-2 Mpro protease provides basis for anti-COVID-19 drug design
Rut, W., Groborz, K., Zhang, L., Sun, X., Zmudzinski, M., Hilgenfeld, R., Drag, M.
10.1101/2020.03.07.981928 — Posted: 2020-03-08 Discussion: Onsite
AI-aided design of novel targeted covalent inhibitors against SARS-CoV-2
Tang, B., He, F., Liu, D., Fang, M., Wu, Z., Xu, D.
10.1101/2020.03.03.972133 — Posted: 2020-03-08
Appealing for Efficient, Well Organized Clinical Trials on COVID-19
Zhao, Y., Wei, Y., Shen, S., Zhang, M., Chen, F.
10.1101/2020.03.05.20031476 — Posted: 2020-03-07
Genome-wide data inferring the evolution and population demography of the novel pneumonia coronavirus (SARS-CoV-2)
Shu, Y.
10.1101/2020.03.04.976662 — Posted: 2020-03-07 Discussion: Onsite
Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites
Chen, S., Kang, S., Yang, M., Hong, Z., Zhang, L., Huang, Z., Chen, X., He, S., Zhou, Z., Zhou, Z., Chen, Q., Yan, Y., Zhang, C., Shan, H.
10.1101/2020.03.06.977876 — Posted: 2020-03-07
Monoclonal antibodies for the S2 subunit of spike of SARS-CoV cross-react with the newly-emerged SARS-CoV-2
Zheng, Z., Monteil, V. M., Maurer-Stroh, S., Yew, C. W., Leong, C., Mohd-Ismail, N. K., Arularasu, S. C., Chow, V. T. K., Lin, R. T. P., Mirazimi, A., Hong, W., Tan, Y.-J.
10.1101/2020.03.06.980037 — Posted: 2020-03-07 Discussion: Onsite
LY6E impairs coronavirus fusion and confers immune control of viral disease
Pfaender, S., Mar, K. B., Michailidis, E., Kratzel, A., Hirt, D., V'kovski, P., Fan, W., Ebert, N., Stalder, H., Kleine-Weber, H., Hoffmann, M., Hoffmann, H. H., Saeed, M., Dijkman, R., Steinmann, E., Wight-Carter, M., Hanners, N. W., Pohlmann, S., Gallagher, T., Todt, D., Zimmer, G., Rice, C. M., Schoggins, J. W., Thiel, V.
10.1101/2020.03.05.979260 — Posted: 2020-03-07 Discussion: Onsite
Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis Mechanisms of SARS-Related Coronaviruses
Tan, Y., Schneider, T., Leong, M., Aravind, L., Zhang, D.
10.1101/2020.03.04.977736 — Posted: 2020-03-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).